These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Trial clouds use of niacin with a statin. Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606 [No Abstract] [Full Text] [Related]
8. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events. Davidson MH Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853 [No Abstract] [Full Text] [Related]
9. Dramatic lowering of very high Lp(a) in response to niacin. Li M; Saeedi R; Rabkin SW; Frohlich J J Clin Lipidol; 2014; 8(4):448-50. PubMed ID: 25110227 [TBL] [Abstract][Full Text] [Related]
14. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Sazonov V; Maccubbin D; Sisk CM; Canner PL Int J Clin Pract; 2013 Apr; 67(4):297-302. PubMed ID: 23521322 [TBL] [Abstract][Full Text] [Related]
15. Effects of HDL-modifiers on cardiovascular outcomes: a meta-analysis of randomized trials. Verdoia M; Schaffer A; Suryapranata H; De Luca G Nutr Metab Cardiovasc Dis; 2015 Jan; 25(1):9-23. PubMed ID: 25439661 [TBL] [Abstract][Full Text] [Related]
16. The therapeutic role of niacin in dyslipidemia management. Boden WE; Sidhu MS; Toth PP J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242 [TBL] [Abstract][Full Text] [Related]
17. Clinical trial endpoints: angiograms, events, and plaque instability. Ballantyne CM Am J Cardiol; 1998 Sep; 82(6A):5M-11M. PubMed ID: 9766342 [TBL] [Abstract][Full Text] [Related]
18. The effect of intensive lipid lowering on coronary atheroma and clinical outcome. Houslay ES; Sarma J; Uren NG Heart; 2007 Feb; 93(2):149-51. PubMed ID: 17035507 [TBL] [Abstract][Full Text] [Related]
19. Role of niacin in current clinical practice. Sharma A; Madan N Minerva Med; 2019 Feb; 110(1):79-83. PubMed ID: 30334440 [TBL] [Abstract][Full Text] [Related]
20. Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). Canner PL; Furberg CD; McGovern ME Am J Cardiol; 2006 Feb; 97(4):477-9. PubMed ID: 16461040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]